Clinical Trials and Research
Children’s cancers are very different than adult cancers and must be treated with specific pediatric cancer protocols. Our experience in exclusively treating children, adolescents and young adults (AYA) makes us the experts in the evaluation and treatment of all forms of common childhood and AYA cancers. We are dedicated to administering the very latest pediatric cancer treatment options. A majority of our treatment protocols come from the Children’s Oncology Group (COG), a national organization funded by the National Cancer Institute (NCI). We are also a member of several multi-institutional consortia that offer innovative treatments of pediatric lymphomas. Several pharma industries sponsored clinical trials for lymphomas are open at CHOC as well. In addition, we are offering individualized treatment approaches for patients with rare or unusual types of lymphomas or refractory disease.